Role of Leptin and SOCS3 in Inhibiting the Type I Interferon Response During Obesity

Inflammation. 2017 Feb;40(1):58-67. doi: 10.1007/s10753-016-0452-x.

Abstract

Obesity provokes an imbalance in the immune system, including an aberrant type I interferon response during some viral infections and after TLR stimulation. SOCS3 overexpression and altered systemic leptin levels could be responsible for the reduced type I interferon production in people with obesity and, eventually, significantly increase the risk of viral infection. The aim of this study was to determine whether SOCS3- and leptin-induced tolerance are responsible for the reduced type I interferon production in people with obesity. SOCS3 overexpression in PBMCs from people with obesity was inhibited with the small interfering RNA (siRNA) assay, and leptin-induced tolerance was evaluated in PBMCs from non-obese volunte\ers and U937 cells treated with TLR ligands. SOCS3, but not SOCS1, gene silencing via siRNA increased the type I interferon response in PBMCs obtained from people with obesity. On the other hand, leptin induced SOCS3 expression and inhibited type I interferons in PBMCs from healthy donors and in U937 monocytes stimulated with TLR ligands. Taken together, these results demonstrate that reduced type I interferon production in obesity is caused by SOCS3 overexpression as well as tolerance induced by leptin. Here, we demonstrate a key role of leptin and SOCS3 in inhibiting the type I interferon response during obesity.

Keywords: SOCS3; leptin; obesity; toll-like receptor; type I interferon.

MeSH terms

  • Cells, Cultured
  • Humans
  • Interferon Type I / antagonists & inhibitors*
  • Leptin / physiology*
  • Ligands
  • Monocytes
  • Obesity / metabolism*
  • Suppressor of Cytokine Signaling 3 Protein / physiology*
  • Toll-Like Receptors
  • U937 Cells

Substances

  • Interferon Type I
  • Leptin
  • Ligands
  • SOCS3 protein, human
  • Suppressor of Cytokine Signaling 3 Protein
  • Toll-Like Receptors